UNSPSC 51124400: Antiarrythmic cardiac glycosides or cardenolides

This classification denotes c(23)-steroids with methyl groups at c-10 and c-13 and a five-membered c-17 lactone, substances chemically called cardenolides, many of which constitute cardiac glycosides -- or Cyclopentanophenanthrenes that adhere to the aforesaid structure but also bind sugars at position 3 - and that prevent or treat irregular heartbeat, disturbances of normal rhythmic heart beating, or normal operation of myocardial contraction, thus the term ANTIARRYTHMIC CARDIAC GLYCOSIDES OR CARDENOLIDES.

UNSPSC 51124400 Antiarrhythmic cardiac glycosides or cardenolides, a Class code, nominally encompasses specialty pharmaceutical products, but recent state and local procurement activity shows little direct alignment with the code's scope. The City of Tampa's sealed-bid solicitation for Advanced Life Support Medications (Bid No. 26P00188), posted April 24, 2026, includes four specific medication line items — Labetalol HCI, Epinephrine, Adenosine, and Diltiazem — none of which are antiarrhythmic cardiac glycosides. The solicitation calls for emergency medical supply procurement to support Tampa Fire Rescue operations. While municipal purchasing departments and emergency services procurement offices are typical issuing bodies under pharmacy and pharmaceutical codes, this particular opportunity is misaligned with the code's nominal category.

The single recent opportunity under this code stems from the City of Tampa, a municipal purchasing body in Florida. The solicitation requires vendors to supply medications with nine-month-minimum expiration dates and delivery within ten calendar days of order placement, carries an estimated contract value of $40,000.00, and features a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount not to exceed $10,000. Electronic bid submission through OpenGov eProcurement closes April 8, 2026, with award to the lowest responsive, responsible bidder within 120 days; the contract term runs one year from award with two optional one-year renewals plus up to three additional 30-day extensions. Vendors must provide Safety Data Sheets compliant with OSHA standards and accessibility documentation meeting WCAG 2.2 Level AA requirements. The code shows minimal recent state and local activity, and the single posted opportunity does not reflect the antiarrhythmic cardiac glycoside scope the code name suggests.